Virtual Medicinal Product (VMP)
-
Olanzapine 10mg powder for solution for injection vials
Name Details
Current Name
Olanzapine 10mg powder for solution for injection vials
|
Start Date
09-06-2004
|
End Date
|
Previous Name
Olanzapine 10mg injection vials
|
Start Date
10-02-2004
|
End Date
08-06-2004
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1
- UDFS UOM
- vial
- Unit Dose UOM
- vial
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Intramuscular
- Form
- Powder for solution for injection
- Ontology Form/Route
- solutioninjection.intramuscular
- Non-availability Indicator
- Actual Products Available
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
N05AH03
BNF |
Current BNF
04020100
|
Start Date
04-04-2022
|
End Date
|
Previous BNF
04020100
|
Start Date
03-02-2005
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
5818311000001104 |
10-02-2004 |
|
VMP Ingredients
VMP ingredients table
Olanzapine |
Based on Ingredient Substance |
|
10 mg |
|
Name
Olanzapine
Basis of strength description
Based on Ingredient Substance
BOSS
Strength and UOM (Nmr)
10
Strength and UOM (Dmr)
Parent Products
-
VTM
Olanzapine
-
VMP
(Current) Olanzapine 10mg powder for solution ...
Virtual Medicinal Product Pack (VMPP) Information
1 vial |
3595 |
Part VIIIA Category C |